Morningstar Investment Services made headlines by reducing their stake in CVS Health, a move shaking investor confidence.

Current parameters surrounding CVS Health represent a biased reward/risk ratio. Click here to see why I upgraded my rating of ...

Market is valued at USD 10.25 Billion in 2024 and is projected to reach a value of USD 610.1 Billion by 2035 at a CAGR ...

CVS Health (CVS) closed the most recent trading day at $61.96, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.01% loss on the day. Elsewhere, the Dow lost 0.32%, ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

The public is being invited to provide feedback with the asset manager planning to submit an application to the city council ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Nuvem, a tech-enabled pharmacy service for community health providers, announced the addition of four seasoned executives to ...

Market Cap: $959.2 billion Originally founded by Martin Eberhard and Marc Tarpenning in 2003, Tesla (NASDAQ:TSLA) is an electric vehicle company accelerating the world’s transition to sustainable ...

Caremark to pay $95M in Pennsylvania, as Louisiana attorney general unleashes trio of lawsuits against CVS Health ...

Louisiana filed several lawsuits against pharmaceutical giant CVS for what it called unfair, deceptive, and unlawful practices.

Louisiana’s attorney general accuses CVS and Caremark of using patient data to push legislation and inflating drug prices, harming patients and local pharmacies.